Back to Prevention

How Does PrEP Actually Work in the Body?

How Does PrEP Actually Work in the Body?
Bareback Guide 5 October 2025

PrEP works by ensuring that antiretroviral drug is already present in the tissues HIV would need to infect. When the virus arrives, it cannot complete the step it depends on, so no infection establishes. The distinction from treatment is timing rather than pharmacology: the same drugs are used, but they are in place before exposure rather than after.

Which drugs are involved?

The standard combination in the UK is tenofovir disoproxil with emtricitabine, usually as a single generic tablet. Both belong to a class called nucleoside and nucleotide reverse transcriptase inhibitors, and both are also used as components of HIV treatment.

What do they actually do?

HIV is a retrovirus, which means it carries its genetic material as RNA and must convert it into DNA before it can integrate into a human cell and start replicating. The enzyme that performs this conversion is reverse transcriptase. Tenofovir and emtricitabine are structural mimics of the natural building blocks that enzyme uses. When reverse transcriptase incorporates one, it cannot attach the next link in the chain, and the process stops. The viral genetic material is never completed and never integrates.

Why do tissue levels matter?

Because HIV encounters the body at mucosal surfaces, particularly the rectal lining, before it reaches the bloodstream. Protection depends on drug concentration in those tissues and in the immune cells within them, not simply on levels in blood. This is why PrEP takes days rather than hours to become fully protective, and why the timing advice differs between types of sex: rectal tissue accumulates tenofovir relatively quickly, while vaginal and frontal tissue takes longer to reach the same protective concentration.

How forgiving is it?

Tenofovir persists inside cells for a considerable time after each dose, in a form the body has already activated. This intracellular reservoir is why daily PrEP tolerates the occasional missed dose without protection collapsing, and why studies have found high effectiveness in men taking four or more doses a week for anal sex. It is a buffer rather than a licence, but it is a real one.

Why does event-based dosing work?

The two-one-one schedule uses a double dose two to twenty-four hours before sex to load rectal tissue rapidly, followed by single doses at twenty-four and forty-eight hours to maintain the level while any exposed cells pass through the vulnerable window. It is established for anal sex in cisgender men, and is not recommended for vaginal or frontal sex because those tissues do not load quickly enough for the schedule to work.

Why does it not prevent anything else?

Because reverse transcriptase is specific to retroviruses. Bacteria such as gonorrhoea, chlamydia and syphilis do not use it, and neither do the viruses causing herpes, hepatitis A or mpox. PrEP is a targeted intervention against one pathogen, which is why regular screening and vaccination remain necessary alongside it.

What does it do to hepatitis B?

Both drugs are active against hepatitis B, which is why status is checked before starting. Someone with chronic hepatitis B who takes PrEP is suppressing it inadvertently, and stopping abruptly can cause a serious flare. This is a genuine reason to plan stopping with a clinic rather than simply running out.

What does this mean practically?

Take it consistently so tissue levels stay above the protective threshold, allow the loading period before relying on it, and understand that its protection is specific. The mechanism explains most of the practical advice, which is why it is worth knowing.